ATT-001

N/A

Report date: 2026/02/27 20:01:47
NME

Base Information

Drug NameATT-001
Drug Alias Nameiodine-123 labeled ATT-001ATT001ATT-001THG 009123I-ATT-001
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Iodine > 123IRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheragnostics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTheragnostics LtdAriceum Therapeutics GmbH
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A